Pamrevlumab
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | CTGF |
| Clinical data | |
| Other names | FG-3019 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6492H10018N1718O2086S48 |
| Molar mass | 147050.38 g·mol−1 |
Pamrevlumab (INN; development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein.
This drug was developed by FibroGen, Inc.